Literature DB >> 11421105

Heterozygosity for the H63D mutation in the hereditary hemochromatosis (HFE) gene may lead into severe iron overload in beta-thalassemia minor: observations in a thalassemic kindred.

G J Ruiz-Argüelles1, J Garcés-Eisele, V Reyes-Núñez, J Sánchez-Anzaldo, G J Ruiz-Delgado, C Jiménez-González, B Carrera.   

Abstract

Heterozygosity for beta-thalassemia (minor) by itself does not lead into iron overload; however, when it is inherited together with a homozygous state for either the H63D or the C282Y mutations of the hereditary hemochromatosis gene (HFE gene), iron overload may ensue. We describe here a kindred in which the propositus, being heterozygote for beta-thalassemia and the H63D mutation of the HFE gene, developed severe iron overload and in turn, chronic liver failure with portal hypertension. Other members of the family with either beta-thalassemia or heterozygous for the H63D gene mutation did not develop iron overload. The interaction between beta-thalassemia and hereditary hemochromatosis is briefly discussed and speculations about other possible genetic mutations leading into familial iron loading are done.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11421105

Source DB:  PubMed          Journal:  Rev Invest Clin        ISSN: 0034-8376            Impact factor:   1.451


  3 in total

1.  Effect of the Hemochromatosis Mutations on Iron Overload among the Indian β Thalassemia Carriers.

Authors:  Anita H Nadkarni; Aradhana A Singh; Stacy Colaco; Priya Hariharan; Roshan B Colah; Kanjaksha Ghosh
Journal:  J Clin Lab Anal       Date:  2016-08-26       Impact factor: 2.352

2.  The Effects of HFE Polymorphisms on Biochemical Parameters of Iron Status in Arab Beta-Thalassemia Patients.

Authors:  Suad AlFadhli; Matra Salem; D K Shome; Najat Mahdi; Rasheeba Nizam
Journal:  Indian J Hematol Blood Transfus       Date:  2017-01-18       Impact factor: 0.900

Review 3.  Diagnosis and Management of Genetic Iron Overload Disorders.

Authors:  William C Palmer; Prakash Vishnu; William Sanchez; Bashar Aqel; Doug Riegert-Johnson; Leigh Ann Kenda Seaman; Andrew W Bowman; Candido E Rivera
Journal:  J Gen Intern Med       Date:  2018-09-17       Impact factor: 6.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.